Stat Labs develops novel CRISPR-based gene editing tools for therapeutic applications. Their technology aims to precisely modify DNA sequences to correct genetic mutations and treat a range of diseases.
Funding
Funding not disclosed
Founders
Product
Problem
Clinicians face challenges in efficiently translating research findings into practical tools for surgery and medicine. The development of bespoke technologies to address specific clinical needs often requires significant time and resources.
Solution
Stat Labs is a clinician-led research and deployment firm that leverages artificial intelligence to develop and deploy novel technologies for medicine and surgery. The company partners with clinician scientists from universities and hospital networks to create tailored solutions for complex medical challenges. Stat Labs focuses on translational research, rapidly developing tools with immediate applications in clinical practice, aiming to improve patient outcomes through AI-powered operations. Their offerings include AI-driven tools for dental clinics, enhanced virtual surgical planning, and databases of clinical anatomy.
Target Audience
The primary target audience includes clinician scientists, doctors, and dental professionals in universities, hospital networks, and institutional dental clinics.
Features
- Rebrief™ Ambient AI for dental professionals, providing AI-driven assistance during clinical practice.
- Enhanced Virtual Surgical Planning tools for maxillary reconstruction, improving surgical precision and outcomes.
- 3D Database of Clinical Oral and Maxillofacial Anatomy, offering a comprehensive resource for research and education.
- ClinicGPT Large Language Model for Institutional Dental Clinics, streamlining workflows and enhancing patient care.